ANOVA PANCAN result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 19:01:10 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: panCancer
Individual drug analysis: 159
Drug details and screening numbers
Drug Name: HG-6-64-1
Drug ID: 159
Synonyms: KIN001-206
Brand name:
Target: BRAFV600E, TAK, MAP4K5
Number of cell lines screened: 880
Screening concentration range(s): 0.02 to 5.12 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a201 |
BCR-ABL_mut |
159 |
1 |
1 |
HG-6-64-1 |
BRAFV600E, TAK, MAP4K5 |
5 |
872 |
1.63 |
1.02 |
-2.76 |
-3.78 |
2.3 ** |
2.3 ** |
3 ** |
8.53e-05 |
6.53e-26 |
1.34e-01 |
7 |
All-tests volcano plot